BlackRock, Inc.

Holdings History for Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV)

Symbol: INDV on Nasdaq
Investment type: Equity / Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares")
Latest Disclosed Shares Owned: 17,806,183 shares
Security Ownership %: 14%

Shares, Excluding Options vs Price

Value, Excluding Options

BlackRock, Inc. ownership in Indivior Pharmaceuticals, Inc. Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV)

08 Jan 2026 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 17,806,183 shares of Indivior Pharmaceuticals, Inc. Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV). This represents 14% ownership of the company. In their previous filing dated 17 Jul 2025, BlackRock, Inc. had reported owning 8,467,176 shares, indicating an increase of +110%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BlackRock, Inc.	14%	+107%	$638,884,065	17,806,183	+9,339,007	+110%	$35.88	13G/A	31 Dec 2025	08 Jan 2026, 13:25
BlackRock, Inc.	6.8%		$125,753,651	8,467,176			$14.85	13G	30 Jun 2025	17 Jul 2025, 19:44

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	+0.01%	$654,111,738	18,230,539	+9,501,401	+109%	$35.88	Q4 2025
30 Sep 2025	0%	+0%	$210,459,516	8,729,138	+3,044,560	+54%	$24.11	Q3 2025
30 Jun 2025	0%	+0%	$83,790,680	5,684,578	+5,617,001	+8312%	$14.74	Q2 2025
31 Mar 2025	0%	-0%	$644,009	67,577	-36,059	-35%	$9.53	Q1 2025
31 Dec 2024	0%	+0%	$1,288,196	103,636	+103,636	NEW	$12.43	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.